AI, Neuromodulation & Thrombectomy Drive $7.6B Growth in U.S. Neurological Devices Market – New iData Research Report Forecasts $10B by 2030

VANCOUVER, BC, April 15, 2025 /PRNewswire/ – A new U.S. Neurological Devices Market Report provides essential insights for CEOs, CFOs, product and marketing managers in the neurology and neurosurgery sectors, helping executives navigate regulatory uncertainty, enabling product teams to adapt to emerging technologies like AI and neuromodulation, and equipping commercial leaders with data to uncover high-growth segments and revenue opportunities in a rapidly evolving neurological devices market.

Produced by iData Research, a leading medical consulting and market research firm, this comprehensive neurology report offers deep analysis of technological disruption, regulatory shifts, and emerging clinical needs impacting profitability and competitive advantage in the neurological devices market.

“As neurology evolves through AI, minimally invasive neuromodulation, and real-time stroke treatment, market leaders must act fast,” said Dr. Kamran Zamanian, CEO of iData Research. “This report arms decision-makers with the intelligence needed to compete in a highly innovative and patient-driven neurology field.”

From Therapy to Tech: The New Era of Neurological Devices in the U.S.

Driven by innovations in neuromodulation, neurovascular intervention, and diagnostic AI, the U.S. neurological devices market exceeded $7.6 billion in 2024 and is forecasted to reach nearly $10 billion by 2030.

Key growth areas include:

  • Minimally invasive neuromodulation, with expanding applications in chronic pain, Parkinson’s disease, epilepsy, and psychiatric conditions
  • Next-gen thrombectomy tools enhancing stroke care outcomes through AI-powered imaging and catheter design
  • Brain-computer interfaces (BCIs) and closed-loop stimulation unlocking new frontiers in adaptive neurotherapy

Key Insights from the Report:

  • Market Risk Assessment: Analyze how AI integration, shifting reimbursement models, and increased competition, are reshaping business strategies and regulatory risk profiles.
  • Growth Segments & Innovation Trends: Track rapid expansion in neuromodulation, neurovascular thrombectomy, and AI-powered diagnostics.
  • Pricing & ASP Dynamics: Understand pricing pressures and margin trends across key device categories including spinal stimulators, aspiration catheters, and intrathecal pumps, with insights into cost-efficiency strategies.
  • Revenue Opportunities: Identify high-growth niches, critical for commercial teams and investors targeting underserved segments.
  • Competitive Landscape: Benchmark leading players like Medtronic, Abbott, and Stryker, while analyzing disruption risks posed by new entrants leveraging AI, cloud imaging, and neuro-intervention platforms.
  • Technology Adoption & Commercial Readiness: Evaluate market adoption curves for emerging tools such as BCIs, AI-driven neuroimaging, AR/VR surgical guidance, and cloud-based data platforms, and their impact on clinical workflow and purchasing decisions.

Who Should Read This Report?

This report is designed for CEOs, CFOs, product and marketing managers, as well as strategic decision-makers within the neurology and neurosurgery sectors looking to make data-driven decisions in the high-growth neurological devices field.

Explore the Market Report

Access a Sample of the Full 2025–2031 U.S. Neurological Devices Market Report, or contact marketing at marketing@idataresearch.net to learn more and see detailed insights into market drivers, growth projections, and strategic opportunities.

About iData Research

iData Research has been a leader in market intelligence for the medical devices industry for over 20 years, delivering data-driven insights that help companies mitigate market risks, optimize pricing strategies, and uncover new revenue opportunities.

Learn more at https://idataresearch.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-neuromodulation–thrombectomy-drive-7-6b-growth-in-us-neurological-devices-market–new-idata-research-report-forecasts-10b-by-2030–302428673.html

SOURCE iData Research Inc.

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

12 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

12 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago